Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia subanalysis of the French aortic national CoreValve and Edwards 2 registry

Circulation: Cardiovascular Interventions

Volumn 7, Issue 4, 2014, Pages 602-610

  Oguri, Atsushi ^a   Yamamoto, Masanori ^a   Mouillet, Gauthier ^a   Gilard, Martine ^b   Laskar, Marc ^c   Eltchaninoff, Helene ^d   Fajadet, Jean ^e   Iung, Bernard ^f   Donzeau Gouge, Patrick ^g   Leprince, Pascal ^h   Leguerrier, Alain ⁱ   Prat, Alain ^j   Lievre, Michel ^k   Chevreul, Karine ^a   Dubois Rande, Jean Luc ^a   Chopard, Romain ^l   Belle, Eric Van ^j   Otsuka, Toshiaki ^m   Teiger, Emmanuel ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

^c DUPUYTREN UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE ROUEN   (France)

^e CLINIQUE PASTEUR   (France)

^f BICHAT HOSPITAL   (France)

^g Jacques Cartier Hospital   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ RENNES UNIVERSITY HOSPITAL   (France)

^j LILLE UNIVERSITY HOSPITAL   (France)

^k UNIVERSITÉ LYON 1   (France)

^l UNIVERSITY HOSPITAL OF BESANÇON   (France)

^m NIPPON MEDICAL SCHOOL   (Japan)

more..

Author keywords

Anesthesia; General; Local

Indexed keywords

ANESTHETIC AGENT;

AGED; AORTA VALVE REGURGITATION; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; INCIDENCE; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS AORTIC VALVE; PRIORITY JOURNAL; PROPENSITY SCORE; RESPIRATORY FAILURE; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; AORTIC VALVE INSUFFICIENCY; COMPARATIVE STUDY; DRUG EFFECTS; FEMORAL ARTERY; FRANCE; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; REGISTER; SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANESTHESIA, GENERAL; ANESTHESIA, LOCAL; AORTIC VALVE INSUFFICIENCY; FEMALE; FEMORAL ARTERY; FRANCE; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; REGISTRIES; SURVIVAL ANALYSIS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84913571733     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.113.000403     Document Type: Article

References (28)

1. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol. 2009;53:1829-1836.
2. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006-3008.
3. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47:1214-1223.
4. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current thirdgeneration self-expanding CoreValve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69-76.
5. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755-763.
6. Marcheix B, Lamarche Y, Berry C, Asgar A, Laborde JC, Basmadjian A, Ducharme A, Denault A, Bonan R, Cartier R. Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. J Thorac Cardiovasc Surg. 2007;134:1150-1156.
7. Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation. 2009;119:3009-3016.
8. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv. 2008;1:167-175.
9. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242-249.
10. Guinot PG, Depoix JP, Etchegoyen L, Benbara A, Provenchère S, Dilly MP, Philip I, Enguerand D, Ibrahim H, Vahanian A, Himbert D, Al-Attar N, Nataf P, Desmonts JM, Montravers P, Longrois D. Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth. 2010;24:752-761.
11. Fassl J, Walther T, Groesdonk HV, Kempfert J, Borger MA, Scholz M, Mukherjee C, Linke A, Schuler G, Mohr FW, Ender J. Anesthesia management for transapical transcatheter aortic valve implantation: a case series. J Cardiothorac Vasc Anesth. 2009;23:286-291.
12. Billings FT IV, Kodali SK, Shanewise JS. Transcatheter aortic valve implantation: anesthetic considerations. Anesth Analg. 2009;108:1453-1462.
13. Klein AA, Webb ST, Tsui S, Sudarshan C, Shapiro L, Densem C. Transcatheter aortic valve insertion: anaesthetic implications of emerging new technology. Br J Anaesth. 2009;103:792-799.
14. Covello RD, Maj G, Landoni G, Maisano F, Michev I, Guarracino F, Alfieri O, Colombo A, Zangrillo A. Anesthetic management of percutaneous aortic valve implantation: focus on challenges encountered and proposed solutions. J Cardiothorac Vasc Anesth. 2009;23:280-285.
15. Dehédin B, Guinot PG, Ibrahim H, Allou N, Provenchère S, Dilly MP, Vahanian A, Himbert D, Brochet E, Radu C, Nataf P, Montravers P, Longrois D, Depoix JP. Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth. 2011;25:1036-1043.
16. Motloch LJ, Rottlaender D, Reda S, Larbig R, Bruns M, Müller-Ehmsen J, Strauch J, Madershahian N, Erdmann E, Wahlers T, Hoppe UC. Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol. 2012;101:45-53.
17. Bergmann L, Kahlert P, Eggebrecht H, Frey U, Peters J, Kottenberg E. Transfemoral aortic valve implantation under sedation and monitored anaesthetic care-a feasibility study. Anaesthesia. 2011;66:977-982.
18. Yamamoto M, Meguro K, Mouillet G, Bergoend E, Monin JL, Lim P, Dubois-Rande JL, Teiger E. Effect of local anesthetic management with conscious sedation in patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2013;111:94-99.
19. Durand E, Borz B, Godin M, Tron C, Litzler PY, Bessou JP, Bejar K, Fraccaro C, Sanchez-Giron C, Dacher JN, Bauer F, Cribier A, Eltchaninoff H. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv. 2012;5:461-467.
20. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge T, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat, A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Sudre A, Blanchard D, Rioufol G, Collet F, Houel R, Caussin C, Meneveau N, Guyon P, Dos Santos P, Collart F, Tirouvanziam A, Boschat J, Delpine S, Le Breton H, Souteyrand G, Faverau X, Laskar M; FRANCE 2 Investigators. Registry of transcatheter aortic valve implantation in high-risk patients. N Engl J Med. 2012;366:1705-1715.
21. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32:205-217.
22. Bufton KA, Augoustides JG, Cobey FC. Anesthesia for transfemoral aortic valve replacement in North America and Europe. J Cardiothorac Vasc Anesth. 2013;27:46-49.
23. Remo DC, Giovanni L, Alberto Z. Anesthetic management of transcatheter aortic valve implantation. Curr Opin Anesthesiol. 2011;24:417-425.
24. Fassl J, Augoustides JG. Transcatheter aortic valve implantation-part 2: anesthesia management. J Cardiothorac Vasc Anesth. 2010;24:691-699.
25. Guarracino F, Covello RD, Landoni G, Baldassarri R, Stefani M, Cariello C, Ruggeri L, Franco A, Gerli C, Pappalardo F, Zangrillo A. Anesthetic management of transcatheter aortic valve implantation with transaxillary approach. J Cardiothorac Vasc Anesth. 2011;25:437-443.
26. Covello RD, Maj G, Landoni G, Maisano F, Michev I, Guarracino F, Alfieri O, Colombo A, Zangrillo A. Anesthetic management of percutaneous aortic valve implantation: focus on challenges encountered and proposed solutions. J Cardiothorac Vasc Anesth. 2009;23:280-285.
27. Chin D. Echocardiography for transcatheter aortic valve implantation. Eur J Echocardiogr. 2009;10:i21-i29.
28. Bagur R, Rodés-Cabau J, Doyle D, De Larochellière R, Villeneuve J, Lemieux J, Bergeron S, Côté M, Bertrand OF, Pibarot P, Dumont E. Usefulness of TEE as the primary imaging technique to guide transcatheter transapical aortic valve implantation. JACC Cardiovasc Imaging. 2011;4:115-124.